secwatch.observer — SEC 8-K summary
======================================

Issuer:     Korro Bio, Inc. (KRRO)
CIK:        0001703647
Form:       8-K
Filed at:   2026-06-11T20:42:29+00:00
Accession:  0001193125-26-267741
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Korro Bio 2026 annual meeting results: directors elected, say-on-pay approved, auditor ratified
--------------------------------------------------------------------------------

- Class I directors Nessan Bermingham and Rachel Meyers elected with 7.47M and 7.37M votes for, respectively.
- Non-binding advisory vote on named executive officer compensation passed: 9.01M for, 27,988 against.
- Ratification of Ernst & Young as independent auditor for FY 2026 approved: 10.92M for, 2,738 against.
- All proposals received strong shareholder support, with broker non-votes only on director and say-on-pay items.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1703647/000119312526267741/0001193125-26-267741-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1703647/000119312526267741/krro-20260610.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-267741

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer